TEOC Oncologia Clínica
TEOC — Título de Especialista em Oncologia Clínica (SBOC, Brazil)
Imunoterapia Toxicidades SuporteEnglish
Exam overviewPractice session
A 58-year-old man receiving nivolumab plus ipilimumab for metastatic melanoma presents on day 10 of cycle 2 with 8 watery bowel movements per day above baseline, severe cramping abdominal pain, and nocturnal diarrhea (CTCAE Grade 3 immune-mediated colitis). Stool pathogen tests and C. difficile PCR are negative. After 48 hours of intravenous methylprednisolone (1.5 mg/kg/day), his symptoms fail to improve. What is the immediate next step in management according to ASCO/ESMO/SBOC toxicity guidelines?
Loading your practice session…